JPS6354001B2 - - Google Patents
Info
- Publication number
- JPS6354001B2 JPS6354001B2 JP56134890A JP13489081A JPS6354001B2 JP S6354001 B2 JPS6354001 B2 JP S6354001B2 JP 56134890 A JP56134890 A JP 56134890A JP 13489081 A JP13489081 A JP 13489081A JP S6354001 B2 JPS6354001 B2 JP S6354001B2
- Authority
- JP
- Japan
- Prior art keywords
- hyaluronic acid
- hyaluronidase
- molecular weight
- intrinsic viscosity
- crest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920002674 hyaluronan Polymers 0.000 claims description 61
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 59
- 229960003160 hyaluronic acid Drugs 0.000 claims description 59
- 108010003272 Hyaluronate lyase Proteins 0.000 claims description 20
- 102000001974 Hyaluronidases Human genes 0.000 claims description 20
- 229960002773 hyaluronidase Drugs 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 239000000284 extract Substances 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 241000287828 Gallus gallus Species 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000011282 treatment Methods 0.000 description 5
- 210000003954 umbilical cord Anatomy 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 108010059712 Pronase Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 4
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004127 vitreous body Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- -1 bird crests Chemical compound 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002031 ethanolic fraction Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002265 redox agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13489081A JPS5837001A (ja) | 1981-08-27 | 1981-08-27 | ヒアルロン酸の製造法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13489081A JPS5837001A (ja) | 1981-08-27 | 1981-08-27 | ヒアルロン酸の製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5837001A JPS5837001A (ja) | 1983-03-04 |
JPS6354001B2 true JPS6354001B2 (de) | 1988-10-26 |
Family
ID=15138900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13489081A Granted JPS5837001A (ja) | 1981-08-27 | 1981-08-27 | ヒアルロン酸の製造法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5837001A (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO161573C (no) * | 1983-11-25 | 1989-08-30 | Miles Inc | Fremgangsmaate til fremstilling av hyaluronsyre. |
JPS60251898A (ja) * | 1984-05-25 | 1985-12-12 | Shiseido Co Ltd | 醗酵法によるヒアルロン酸の製造方法 |
US4784990A (en) * | 1985-01-18 | 1988-11-15 | Bio-Technology General Corporation | High molecular weight sodium hyaluronate |
US4780414A (en) * | 1985-01-18 | 1988-10-25 | Bio-Technology General Corp. | Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus |
SE8501723L (sv) * | 1985-04-09 | 1986-10-10 | Pharmacia Ab | Preparation att anvendas vid behandling av ledinflammation |
EP0221167A4 (de) * | 1985-05-09 | 1988-08-24 | David Cullis-Hill | Herstellung von hyaluronsäure. |
US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
US5202431A (en) * | 1985-07-08 | 1993-04-13 | Fidia, S.P.A. | Partial esters of hyaluronic acid |
JPH01502964A (ja) * | 1986-06-18 | 1989-10-12 | サルフォン プロプライエタリー リミテッド | 蒸留装置および方法 |
EP0891775A4 (de) * | 1996-12-27 | 2002-07-24 | Seikagaku Kogyo Co Ltd | Heilmittel gegen harnblasenstoerungen |
JP2002003396A (ja) * | 2000-06-20 | 2002-01-09 | Adaputogen Seiyaku Kk | 免疫増強剤及びその製造方法 |
KR100395298B1 (ko) * | 2000-07-07 | 2003-08-25 | 아답트겐 세이야쿠 가부시키가이샤 | 면역증강제 및 그 제조방법 |
JP4576583B2 (ja) | 2005-03-22 | 2010-11-10 | キユーピー株式会社 | ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
KR101412776B1 (ko) * | 2013-03-11 | 2014-07-01 | 가톨릭대학교 산학협력단 | 각결막염 치료용 점안제 조성물 및 이의 제조 방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52105199A (en) * | 1976-03-01 | 1977-09-03 | Seikagaku Kogyo Co Ltd | Isolation of acidic polysaccharide |
-
1981
- 1981-08-27 JP JP13489081A patent/JPS5837001A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52105199A (en) * | 1976-03-01 | 1977-09-03 | Seikagaku Kogyo Co Ltd | Isolation of acidic polysaccharide |
Also Published As
Publication number | Publication date |
---|---|
JPS5837001A (ja) | 1983-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6354001B2 (de) | ||
JP4420470B2 (ja) | あわび多糖類抽出方法 | |
EP0140134A2 (de) | Verfahren zur Herstellung eines biologisch aktiven Extraktes | |
CN110538312A (zh) | 一种皮肤创伤修复软膏及其制备方法 | |
DE2440529C3 (de) | Hyaluronidase-Präparat aus menschlicher Plazenta | |
KR101685189B1 (ko) | 전복을 이용한 콜라겐 펩타이드의 제조방법 | |
EP0297455B1 (de) | Zusammensetzung mit anregender Wirkung für die Haare | |
CN108977488B (zh) | 皮肤密集修复用弹性蛋白及其制备方法 | |
EP0966294B1 (de) | Verzweigtes verfahren zur verarbeitung des gesamten aloeblattes | |
JPS62236499A (ja) | 生物学的に活性なポリペプチド、それらの製造方法ならびにそれらを含有する組成物 | |
DE69727736T2 (de) | Verfahren zur Aktivierung von Prothrombin zu Thrombin | |
CN113122604B (zh) | 一种海肠胶及其制备方法和应用 | |
CN113041175B (zh) | 源自鼠尾藻的半乳岩藻聚糖及其在犬猫口腔护理上的应用 | |
CN104725532B (zh) | 一种精确定量控制肝素/类肝素中硫酸软骨素及硫酸皮肤素含量的方法 | |
JP3191956B2 (ja) | アルコール性脂肪肝抑制剤 | |
JPS59166504A (ja) | ヒアルロン酸の製造法 | |
CN105648017A (zh) | 一种哺乳类动物胶原蛋白的提取方法 | |
JP3155746B1 (ja) | Ii型コラーゲンの製造方法 | |
KR102180261B1 (ko) | 돈육 부산물 유래 헤파린의 추출 방법 | |
RU2304441C1 (ru) | Способ получения сульфатированных гликозаминогликанов из биологических тканей | |
JPH07241200A (ja) | ヒアルロン酸の製造法 | |
KR101837118B1 (ko) | 박테리아 배양 산물을 이용한 콜라겐의 추출 방법 | |
KR20190061322A (ko) | 비분획 헤파린의 제조방법 | |
WO2002069984A2 (de) | Verwendung von hyaluronsäure-uroniden zur behandlung von entzündlichen vorgängen | |
JPS6310601A (ja) | コンドロイチン硫酸誘導体 |